Brazil is pursuing "medical sovereignty" by building domestic vaccine and pharmaceutical manufacturing capacity, refusing reliance on external supply chains. This mirrors a broader global trend of nations seeking AI sovereignty, the drive to develop indigenous AI capabilities rather than depend on foreign models and infrastructure.
The strategy reflects legitimate concerns about supply chain vulnerabilities. Brazil learned hard lessons during the pandemic when international medicine supplies became unreliable. Public institutions now produce much of the country's pharmaceuticals domestically. The same logic applies to AI: countries that lack their own large language models and computing infrastructure face strategic disadvantages and exposure to foreign policy disruptions.
AI sovereignty encompasses multiple layers. Nations want homegrown AI models trained on local data. They need domestic chip manufacturing or at least supply guarantees. They require cloud infrastructure under national control. Brazil, like many countries, recognizes that outsourcing AI development to a handful of American or Chinese companies creates structural dependencies incompatible with genuine independence.
The economic argument extends beyond geopolitics. Building local AI capacity creates jobs, retains intellectual property value domestically, and allows customization for local languages and regulatory environments. A model trained exclusively on English data performs worse in Portuguese or Spanish. Healthcare AI needs to understand local disease patterns and medical practices.
However, pursuing complete AI sovereignty carries costs. It fragments the global AI ecosystem, duplicates expensive R&D, and slows innovation. Smaller nations lack the compute resources to train frontier models. Some countries may use sovereignty rhetoric to justify surveillance or content control under the guise of national protection.
The realistic middle ground involves strategic autonomy rather than total independence. Nations can build capacity for fine-tuning and deploying models, invest in sector-specific AI applications, and develop regulatory frameworks suited to local values. Open-source models offer a path forward, providing starting points that countries can adapt without complete reliance on proprietary systems controlled by foreign corporations.
Brazil's medical sovereignty model suggests the